Koru Lifescience
Pharmaceutical research and development organisation founded in 2017 focused on formulation and platform-based drug development, drug repurposing, and personalised/stratified medicine. Offers contract development and collaborative R&D services spanning formulation, analytical development, stability testing, a range of dosage forms, advanced manufacturing techniques and computational screening to accelerate development of therapies.
Industries
Nr. of Employees
medium (51-250)
Koru Lifescience
Products
Melt extrusion or nozzle based deposition system (Fused Deposition modelling)
A key platform utilized for 3D printing of pharmaceutical dosage forms.
Selective Laser Sintering (SLS)
A key platform utilized for 3D printing of pharmaceutical dosage forms.
Direct Powder Extrusion
A key platform utilized for 3D printing of pharmaceutical dosage forms.
Melt extrusion or nozzle based deposition system (Fused Deposition modelling)
A key platform utilized for 3D printing of pharmaceutical dosage forms.
Selective Laser Sintering (SLS)
A key platform utilized for 3D printing of pharmaceutical dosage forms.
Direct Powder Extrusion
A key platform utilized for 3D printing of pharmaceutical dosage forms.
Services
Contract research and development services covering formulation development, analytical development, stability studies, regulatory and clinical affairs support and IP advisory.
Contract research and development services covering formulation development, analytical development, stability studies, regulatory and clinical affairs support and IP advisory.
Expertise Areas
- Formulation development
- Analytical development and stability testing
- Drug repurposing and repositioning
- Personalised and stratified medicine
Key Technologies
- 3D printing (Fused deposition modelling, Direct powder extrusion, SLS)
- Hot-melt extrusion
- Twin-screw extrusion
- Spray drying